Phase 2 Hypereosinophilic Syndrome Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents

Hypereosinophilic Syndrome

National Institute of Allergy and Infectious Diseases (NIAID)30 enrolled1 locationNCT06477653

Recruiting

Phase 2

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

Blasts More Than 5 Percent of Bone Marrow Nucleated CellsChronic Eosinophilic Leukemia-not Otherwise SpecifiedBCR-JAK2 Fusion Protein Expression+9 more

William Shomali10 enrolled4 locationsNCT03801434